Proteome Sciences (PRM) Competitors GBX 3.07 +0.35 (+12.94%) (As of 12/20/2024 07:20 AM ET) Add Compare Share Share Competitors Stock AnalysisChartCompetitorsHeadlines PRM vs. MOS, VGAS, ALB, ADES, LOOP, PPG, REX, SMG, PCT, and SLIShould you be buying Proteome Sciences stock or one of its competitors? The main competitors of Proteome Sciences include Mobile Streams (MOS), Volga Gas (VGAS), Albert Technologies (ALB), ADES International (ADES), LoopUp Group (LOOP), Plutus PowerGen (PPG), 3260041 (REX.L) (REX), 646143 (SMG.L) (SMG), Polar Capital Technology Trust (PCT), and Standard Life Investments Property Income Trust (SLI). These companies are all part of the "chemicals" industry. Proteome Sciences vs. Mobile Streams Volga Gas Albert Technologies ADES International LoopUp Group Plutus PowerGen 3260041 (REX.L) 646143 (SMG.L) Polar Capital Technology Trust Standard Life Investments Property Income Trust Proteome Sciences (LON:PRM) and Mobile Streams (LON:MOS) are both small-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their analyst recommendations, institutional ownership, dividends, risk, valuation, profitability, earnings, media sentiment and community ranking. Which has more risk and volatility, PRM or MOS? Proteome Sciences has a beta of 0.07, indicating that its share price is 93% less volatile than the S&P 500. Comparatively, Mobile Streams has a beta of -0.4, indicating that its share price is 140% less volatile than the S&P 500. Does the media prefer PRM or MOS? In the previous week, Proteome Sciences' average media sentiment score of 0.00 equaled Mobile Streams'average media sentiment score. Company Overall Sentiment Proteome Sciences Neutral Mobile Streams Neutral Which has preferable valuation and earnings, PRM or MOS? Mobile Streams has lower revenue, but higher earnings than Proteome Sciences. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioProteome Sciences£4.04M2.24-£4.08M-£0.01-307.20Mobile Streams£1.82M18.70-£2.85MN/AN/A Is PRM or MOS more profitable? Mobile Streams has a net margin of 0.00% compared to Proteome Sciences' net margin of -101.07%. Proteome Sciences' return on equity of 0.00% beat Mobile Streams' return on equity.Company Net Margins Return on Equity Return on Assets Proteome Sciences-101.07% N/A -19.25% Mobile Streams N/A -165.33%-58.95% Do institutionals & insiders have more ownership in PRM or MOS? 23.0% of Proteome Sciences shares are owned by institutional investors. Comparatively, 0.1% of Mobile Streams shares are owned by institutional investors. 19.5% of Proteome Sciences shares are owned by insiders. Comparatively, 34.8% of Mobile Streams shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term. Does the MarketBeat Community prefer PRM or MOS? Proteome Sciences received 47 more outperform votes than Mobile Streams when rated by MarketBeat users. Likewise, 57.04% of users gave Proteome Sciences an outperform vote while only 53.49% of users gave Mobile Streams an outperform vote. CompanyUnderperformOutperformProteome SciencesOutperform Votes16257.04% Underperform Votes12242.96% Mobile StreamsOutperform Votes11553.49% Underperform Votes10046.51% SummaryProteome Sciences beats Mobile Streams on 7 of the 12 factors compared between the two stocks. Ad Behind the MarketsWARNING: “Buffett Indicator” flashing for first time in 50 yearsWarren Buffett has sold a staggering $97 billion worth of stocks this year... But why? Our research indicates the Oracle of Omaha is quietly preparing for a historic market crash. His most reliable crash indicator - the "Buffett indicator" - just flashed red for the first time in 25 years.Take these 4 steps today to protect your retirement NOW Get Proteome Sciences News Delivered to You Automatically Sign up to receive the latest news and ratings for PRM and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart PRM vs. The Competition Export to ExcelMetricProteome SciencesDiagnostics & Research IndustryMedical SectorLON ExchangeMarket Cap£9.07M£27.75M£5.14B£1.88BDividend Yield6.17%5.44%5.09%5.54%P/E Ratio-307.202.0090.051,810.29Price / Sales2.242,398.621,117.14382,807.21Price / Cash3.7311.4243.0428.42Price / Book-1.543.044.782.91Net Income-£4.08M£53.40M£120.31M£156.83M7 Day Performance15.92%-3.11%-1.92%-1.92%1 Month Performance33.57%-0.11%11.51%17.93%1 Year Performance-38.25%-14.32%30.61%29.50% Proteome Sciences Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)PRMProteome SciencesN/AGBX 3.07+12.9%N/A-38.3%£9.07M£4.04M-307.20240MOSMobile StreamsN/AGBX 0.35-2.8%N/A+560.7%£26.71M£1.82M-1.2413,600VGASVolga GasN/AGBX 23.50flatN/AN/A£18.99M£18.73M-1.222ALBAlbert TechnologiesN/AGBX 8+56.9%N/A+0.0%£7.98M£4.61M-0.537,400Gap UpHigh Trading VolumeADESADES InternationalN/AGBX 12.35flatN/AN/A£5.09M£452.11M26.62140LOOPLoopUp GroupN/AGBX 0.70+27.3%N/A-71.9%£1.43M£22.07M-5.8390PPGPlutus PowerGenN/AGBX 0.03flatN/AN/A£1.32M£1.17M-0.1952,000REX3260041 (REX.L)N/AN/AN/AN/A£0.00N/A0.00120SMG646143 (SMG.L)N/AN/AN/AN/A£0.00N/A0.006,100High Trading VolumePCTPolar Capital Technology TrustN/AGBX 349+0.4%N/A-86.6%£4.15B£1.15B381.87120News CoveragePositive NewsSLIStandard Life Investments Property Income TrustN/AGBX 79-0.8%N/A+0.0%£312.43M£29.95M3.672,021News Coverage Related Companies and Tools Related Companies Mobile Streams Competitors Volga Gas Competitors Albert Technologies Competitors ADES International Competitors LoopUp Group Competitors Plutus PowerGen Competitors 3260041 (REX.L) Competitors 646143 (SMG.L) Competitors Polar Capital Technology Trust Competitors Standard Life Investments Property Income Trust Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (LON:PRM) was last updated on 12/21/2024 by MarketBeat.com Staff From Our PartnersAmazon coin set to soar 25X – starting December 16th?This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...True Market Insiders | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredVideo: Blindfolded Man Gets Into a Cybertruck… What Happens Next Will Shock You“Hi, I’m Jeff Brown… Even though I can’t see a thing… I’m about to get in this Cybertruck and drive up t...Brownstone Research | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode before 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Proteome Sciences plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Proteome Sciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
